KRAS – the most commonly mutated oncogene in cancer

Amol Akhade shared on X:

“KRAS – the most commonly mutated oncogene in cancer. Nice slide to show the incidence of various types of KRas mutations in various cancers. As of today only, G12C is druggable.”

Source: Amol Akhade/X

Dr. Amol Akhade is a senior consultant medical oncologist and hemato-oncologist. He has received his super specialization training in hemato-oncology and medical oncology from Tata memorial hospital. He specialises in chemotherapy for hematological cancers as well as solid tumors.

He also specialises in allogenic and autologous bone marrow transplant. Currently he is a Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals.